This is a "connection" page, showing publications co-authored by Charles Yeo and Talar Tatarian.
Lowder CY, Dhir T, Goetz AB, Thomsett HL, Bender J, Tatarian T, Madhavan S, Petricoin EF, Blais E, Lavu H, Winter JM, Posey J, Brody JR, Pishvaian MJ, Yeo CJ. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience. Surg Oncol. 2020 Jun; 33:118-125.
Tatarian T, Jiang W, Leiby BE, Grigoli A, Jimbo M, Dabbish N, Neoptolemos JP, Greenhalf W, Costello E, Ghaneh P, Halloran C, Palmer D, Buchler M, Yeo CJ, Winter JM, Brody JR. Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial. Ann Surg. 2016 Nov 23.
Worsh CE, Tatarian T, Singh A, Pucci MJ, Winter JM, Yeo CJ, Lavu H. Total parenteral nutrition in patients following pancreaticoduodenectomy: lessons from 1184 patients. J Surg Res. 2017 Oct; 218:156-161.